45
Views
17
CrossRef citations to date
0
Altmetric
SHORT COMMUNICATION

INTERLEUKIN-6 PROMOTER POLYMORPHISM AND LATE-ONSET ALZHEIMER's DISEASE IN THE FINNISH POPULATION

, , , , , , , , , , , & show all
Pages 155-161 | Received 01 Aug 2005, Accepted 02 Dec 2005, Published online: 11 Jul 2009

REFERENCES

  • American Psychiatric Association (APA). (1987). Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, revised. Washington, , DC: American Psychiatric Association.
  • Arosio, B., Trabattoni, D., Galimberti, L., Bucciarelli, P., Fasano, F., Calabresi, C., Cazullo, C.L., Vergani, C., Annoni, G., & Clerici, M. (2004). Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease. Neurobiol. Aging 25, 1009–1015, [PUBMED], [INFOTRIEVE], [CSA]
  • Bagli, M., Papassotiropoulos, A., Knapp, M., Jessen, F., Rao, M.L., Maier, W., Heun, R. (2000). Association between an interleukin-6 promoter and 3′ flanking region haplotype and reduced Alzheimer's disease risk in a German population. Neurosci. Lett. 283, 109–112, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Bhojak, T.J., DeKosky, S.T., Ganguli, M., & Kamboh, M.I. (2000). Genetic polymorphisms in the cathepsin D and interleukin-6 genes and the risk of Alzheimer's disease. Neurosci Lett. 288, 21–24, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Breteler, M.M. (2000). Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol. Aging 21, 153–160, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Capurso, C., Solfrizzi, V., D'Introno, A., Colacicco, A.M., Capurso, S.A., Capurso, A., & Panza, F. (2004). Interleukin 6–174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe. Exp. Gerontol. 39, 1567–1573, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Daw, E.W., Payami, H., Nemens, E.J., Nochlin, D., Bird, T.D., Schellenberg, G.D., & Wijsman, E.M. (2000). The number of trait loci in late-onset Alzheimer's disease. Amer. J. Hum. Genet. 66, 196–204, [CROSSREF], [CSA]
  • Enholm, C., Lukka, M., Kuusi, T., Nikkilä, E., & Utermann, G. (1986). Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentration. J. Lipid Res. 27, 227–235, [CSA]
  • Fishman, D., Faulds, G., Jeffery, R., Mohammed-Ali, V., Yudkin, J.S., Humpries, S., & Woo, P. (1998). The effect of novel polymorphisms in the Interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 102, 1369–1376, [PUBMED], [INFOTRIEVE], [CSA]
  • Helkala, E.-L., Koivisto, K., Hänninen, T., Vanhanen, M., Kervinen, K., Kuusisto, J., Mykkänen, L., Kesäniemi, Y.A., Laakso, M., & Riekkinen, P. Sr. (1996). Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study. Neurosci. Lett. 204, 177–180, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Kubaszek, A., Pihlajamäki, J., Punnonen, K., Karhapää, P., Vauhkonen, I., & Laakso, M. (2003). The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity. Diabetes 52, 558–561, [PUBMED], [INFOTRIEVE], [CSA]
  • Licastro, F., Chiapelli, M., Caldarera, C.M., Tampieri, C., Nanna, S., Gallina, M., & Branzi, A. (2004). The concomitant presence of polymorphic alleles of interleukin-1β, interleukin-6 and apolipoprotein E is associated with an increased risk of myocardial infarctation in elderly men. Results from a pilot study. Mech Ageing Devel. 125, 575–579, [CSA]
  • McGeer, E.G. & McGeer, P.L. (1998). The importance of inflammatory mechanisms in Alzheimer disease. Exp. Gerontol. 33, 371–378, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E.M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task force on Alzheimer's Disease. Neurology 34, 939–944, [PUBMED], [INFOTRIEVE], [CSA]
  • Papassotiropoulos, A., Hock, C., & Nitsch, R.M. (2001). Genetics of interleukin 6: implications for Alzheimer's disease. Neurobiol. Aging 22, 863–871, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Pola, R., Flex, A., Gaetani, E., Lago, A.D., Gerardino, L., Pola, P., & Bernabei, R. (2002). The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with Alzheimer's disease in an Italian population. Neuroreport 13, 1645–1647. ( Erratum in Neuroreport 14, 656, 2003.)[PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Shibata, N., Ohnuma, T., Takahashi, T., Baba, H., Ishizuka, T., Ohtsuka, M., Ueki, A., Nagao, M., & Arai, H. (2002). Effect of IL-6 polymorphism on risk of Alzheimer's disease: genotype-phenotype association study in Japanese cases. Am. J. Med. Genet. 114, 436–439, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.